The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Nephrosis, Lipoid

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nephrosis, Lipoid


High impact information on Nephrosis, Lipoid


Chemical compound and disease context of Nephrosis, Lipoid


Biological context of Nephrosis, Lipoid


Anatomical context of Nephrosis, Lipoid


Gene context of Nephrosis, Lipoid


Analytical, diagnostic and therapeutic context of Nephrosis, Lipoid


  1. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Breiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schaffner, G., Kerjaschki, D. Am. J. Pathol. (1997) [Pubmed]
  2. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. Cade, R., Mars, D., Privette, M., Thompson, R., Croker, B., Peterson, J., Campbell, K. Arch. Intern. Med. (1986) [Pubmed]
  3. Expression of podocyte-associated molecules in acquired human kidney diseases. Koop, K., Eikmans, M., Baelde, H.J., Kawachi, H., De Heer, E., Paul, L.C., Bruijn, J.A. J. Am. Soc. Nephrol. (2003) [Pubmed]
  4. Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy. Samuels, B., Lee, J.C., Engleman, E.P., Hopper, J. Medicine (Baltimore) (1978) [Pubmed]
  5. Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note. Tencer, J., Torffvit, O., Thysell, H., Rippe, B., Grubb, A. Kidney Int. (1998) [Pubmed]
  6. Determinants of glomerular hypofiltration in nephrotic patients with minimal change nephropathy. Guasch, A., Myers, B.D. J. Am. Soc. Nephrol. (1994) [Pubmed]
  7. Chronic myelogenous leukemia with nephrotic syndrome. Sudholt, B.A., Heironimus, J.D. Arch. Intern. Med. (1983) [Pubmed]
  8. Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy. Paizis, K., Kirkland, G., Polihronis, M., Katerelos, M., Kanellis, J., Power, D.A. Kidney Int. (1998) [Pubmed]
  9. Detection of diffuse glomerular lesions in rats: I. Comparisons of conventional radioactive agents. McAfee, J.G., Thomas, F.D., Subramanian, G., Lyons, B., Roskopf, M. J. Nucl. Med. (1986) [Pubmed]
  10. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns. Schulman, S.L., Kaiser, B.A., Polinsky, M.S., Srinivasan, R., Baluarte, H.J. J. Pediatr. (1988) [Pubmed]
  11. Ibuprofen-associated lipoid nephrosis without interstitial nephritis. Morgenstern, S.J., Bruns, F.J., Fraley, D.S., Kirsch, M., Borochovitz, D. Am. J. Kidney Dis. (1989) [Pubmed]
  12. Pefloxacin in adriamycin induced nephrotic syndrome in the rat. Korzets, Z., Pomeranz, A., Golan, E., Bernheim, J. Nephrol. Dial. Transplant. (1997) [Pubmed]
  13. Is house dust allergen a possible causal factor for relapses in lipoid nephrosis? Laurent, J., Lagrue, G., Belghiti, D., Noirot, C., Hirbec, G. Allergy (1984) [Pubmed]
  14. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Maher, E.R., Sweny, P., Chappel, M., Varghese, Z., Moorhead, J.F. Nephrol. Dial. Transplant. (1988) [Pubmed]
  15. Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. Feehally, J., Beattie, T.J., Brenchley, P.E., Coupes, B.M., Houston, I.B., Mallick, N.P., Postlethwaite, R.J. N. Engl. J. Med. (1984) [Pubmed]
  16. Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability. Laflam, P.F., Haraguchi, S., Garin, E.H. Nephron (2002) [Pubmed]
  17. Long-term impairment of suppressor-cell function by cyclophosphamide in minimal-change nephropathy and its association with therapeutic response. Taube, D., Brown, Z., Williams, D.G. Lancet (1981) [Pubmed]
  18. Decreased release of IL-10 by monocytes from patients with lipoid nephrosis. Matsumoto, K. Clin. Exp. Immunol. (1995) [Pubmed]
  19. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Mandreoli, M., Beltrandi, E., Casadei-Maldini, M., Mancini, R., Zucchelli, A., Zucchelli, P. Clin. Nephrol. (1992) [Pubmed]
  20. Monoclonal antibody analysis of glomerular and renal interstitial immune cells in steroid-resistant and steroid-responsive minimal change disease in children. Wagrowska-Danilewicz, M., Danilewicz, M. Arch. Immunol. Ther. Exp. (Warsz.) (1996) [Pubmed]
  21. Inner ear damage due to lipoid nephrosis. Yamane, H., Nakai, Y. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. (1993) [Pubmed]
  22. Interleukin 10 and interleukin 13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis. Matsumoto, K., Ohi, H., Kanmatsuse, K. Nephron (1997) [Pubmed]
  23. Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome. Sharif, K., Goyal, M., Kershaw, D., Kunkel, R., Wiggins, R. Exp. Nephrol. (1998) [Pubmed]
  24. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy. Carrie, B.J., Myers, B.D. Kidney Int. (1980) [Pubmed]
  25. Minimal-change nephropathy and malignant thymoma. Varsano, S., Bruderman, I., Bernheim, J.L., Rathaus, M., Griffel, B. Chest (1980) [Pubmed]
  26. Evaluation of adriamycin nephropathy by an in vivo electron paramagnetic resonance. Oteki, T., Nagase, S., Yokoyama, H., Ohya, H., Akatsuka, T., Tada, M., Ueda, A., Hirayama, A., Koyama, A. Biochem. Biophys. Res. Commun. (2005) [Pubmed]
  27. Immunolocalization of fibronectin in recurrent minimal change glomerulonephritis kidney biopsy sections of two acute rejected renal transplant recipients. Mukhtar, A.H. Panminerva medica. (1998) [Pubmed]
  28. Unresolved issues and current concepts in management of primary glomerulonephritis. Dash, S.C., Al-Muhanna, F.A. Annals of Saudi medicine. (2005) [Pubmed]
WikiGenes - Universities